Top Chicago, IL Health Tech Companies With Best Stability & Growth (663)
ZS is a management consulting and technology firm that partners with companies to improve life and how we live it. We transform ideas into impact by bringing together data, science, technology and human ingenuity to deliver better outcomes for all. Founded in 1983, ZS has more than 15,000+ employees in over 40 offices worldwide.
ZS's Top Stability & Growth Strengths
Strong Hiring & Retention: Headcount and hiring momentum are evident, with third-party estimates showing growth from roughly the mid‑teens of thousands in 2024 to 20,000+ by 2025–2026 and plans to hire thousands, alongside new capacity such as the Hyderabad operations center. This suggests the company is scaling delivery and talent depth across geographies.
Innovation-Driven Growth: The firm has expanded into AI and digital offerings, including its ZAIDYN platform, acquisitions like Digital Additive and Torrent Consulting, and launches such as Myelo developed with the International Myeloma Foundation. These moves indicate investment beyond traditional consulting into scalable, tech‑enabled services.
Market Expansion: A dedicated mid‑cap pharmaceutical vertical and the opening of an operations center in Hyderabad point to deliberate expansion in target segments and delivery footprint. These steps signal efforts to broaden served markets and strengthen execution capacity.
Our mission is to improve health outcomes through behavior change at the point of care and beyond. Every day, people make choices that shape their health, and at PatientPoint, we strive to support those decisions with the right information delivered at the right time. We're proud to power the largest network of digital devices in doctor's offices across the country —...
PatientPoint's Top Stability & Growth Strengths
Strong Revenue Growth: Company disclosures point to multi‑year top‑line expansion, with independent credit commentary anticipating continued gains. The scale of the installed healthcare network reinforces commercial traction over time.
Market Expansion: Recent launches of a Consumer Health Network and programmatic advertising capabilities extend reach beyond traditional pharmaceutical clients and open new buying channels. These moves indicate active growth into adjacent advertiser categories within healthcare settings.
Investor Backing & Capital Strength: A definitive agreement to be acquired by a global private‑equity firm underscores institutional confidence and adds resources to accelerate network growth and product innovation. The transaction highlights access to capital to support scaling.
Here at Strata, we provide financial planning software, data, and insights to drive decisions and performance for organizations spanning the healthcare, higher education, and financial services industries.
Strata Decision Technology's Top Stability & Growth Strengths
Market Expansion: Expansion into higher education and financial institutions, coupled with the integration of Syntellis and the acquisition of c. myers, broadened capabilities and reach. This indicates widening commercial avenues beyond the core healthcare base.
Innovation-Driven Growth: New AI-powered offerings—Predictive Analytics and Financial Decision Intelligence—were launched within the StrataJazz platform. These additions signal sustained product investment to deepen value and use cases.
Diversified Customer Base: Strata reports serving more than 2,300 organizations across healthcare, higher education, and financial institutions. This spread reduces reliance on a single sector and provides multiple paths for growth.
Prolaio is a clinical intelligence company dedicated to unlocking continuous, predictive and shareable heart data to liberate patients from hospital-based reactive care and accelerate every new therapy. The company was created by cardiologists, cardiovascular practitioners, and data scientists specifically to address the world’s number one cause of death — cardiovascular disease. By combining scientific rigor with cutting‑edge technology, Prolaio aims...
Prolaio's Top Stability & Growth Strengths
Strong Hiring & Retention: Workforce expansion is evident, with Prolaio reporting 32 new hires in 2025 and continuing to recruit across technical and customer-facing roles. These signals point to organizational scaling backed by ongoing capacity investment.
Product Line Growth: Product capabilities advanced with the launch of the OCORO study and an FDA 510(k) clearance for the eVO2peak module in 2025. These developments broaden the digital cardiovascular biomarker portfolio and can support wider clinical use.
Strategic Partnerships: The 2025 acquisition by Kardigan ties Prolaio’s cardiovascular data platform directly to active drug-development programs. This connection creates avenues for expanded clinical deployments and operational scale.
We are a purpose driven healthcare technology company passionate about innovation and using technology to help people by solving real world problems. The ALIS team designs, builds, delivers, and supports our flagship product ALIS (pronounced “Alice” and stands for Assisted Living Integrated Solution).
ALIS's Top Stability & Growth Strengths
Strong Revenue Growth: Management reported strong revenue growth in the prior year alongside expanded market share. A larger Chicago office and plans to scale headcount were presented as aligned with this momentum.
Product Line Growth: The platform has expanded from EHR/eMAR into CRM, billing, business intelligence, family engagement, and AI, and it added dementia and behavioral‑care tools through the Ella and elbi acquisition in 2026. Continued integrations and an AI assistant indicate active product development.
Market Expansion: The company cites use across more than 3,000 communities and 200,000 residents in 40+ states. New and expanded integrations throughout 2026 support broader reach and stickiness with operators.
We bring together one of the world’s largest libraries of multimodal clinical and molecular data with a robust suite of AI tools to help physicians personalize care in real time, connect patients with therapies and clinical trials, and enable partners to accelerate discovery and development of new treatments. With ~8 million de-identified research records and 350+ petabytes of data, Tempus partners...
Tempus AI's Top Stability & Growth Strengths
Strong Revenue Growth: Recent financial results highlight sustained top-line expansion with rising quarterly revenue and management increasing full‑year guidance, indicating momentum across 2025 and into 2026.
Diversified Revenue Streams: Growth is coming from both diagnostics and data licensing/AI applications, with testing volumes and data contracts expanding rather than reliance on a single line of business.
Customer Loyalty & Retention: Reported net revenue retention above 100% and sizable remaining contract value suggest existing pharmaceutical customers are deepening engagements.
EliseAI builds vertical AI agents for housing and healthcare — sectors that together make up nearly 40% of household spending. These agents automate high-volume workflows like leasing, maintenance, renewals, and patient intake, helping organizations cut costs, improve efficiency, and deliver better experiences. How does it work? EliseAI integrates directly into operational workflows: Housing: Manages leasing, maintenance, renewals, billing, and resident communication. Healthcare: Handles intake,...
EliseAI's Top Stability & Growth Strengths
Strong Revenue Growth: Reported ARR surpassed $200 million in June 2026 with five consecutive years of 100% year-over-year growth, indicating rapid scaling. Adoption breadth, including claims of powering one in six U.S. apartments, reinforces the commercial momentum behind that trajectory.
Investor Backing & Capital Strength: A $350 million round in September 2026 at a $4 billion valuation, with major existing investors participating alongside Ontario Teachers’ Pension Plan, underscores substantial access to capital. This financing signals strong confidence to fund continued product development and go-to-market expansion.
Market Expansion: Reach reportedly grew from about one in twelve U.S. apartments in 2024 to one in six in 2026, alongside plans for a second engineering hub in San Francisco. The company is also expanding from leasing into broader property-management workflows and healthcare administration.
IntellaTriage provides 24/7 nurse-first telephone triage and patient-engagement services for hospice and home-health organizations, health plans, physician groups, and other providers. Its licensed, triage-trained nurses follow provider-specific protocols, document encounters in electronic medical records, and deliver nurse advice and post-discharge follow-up. The company aims to improve patient experience and care outcomes while reducing nurse burnout and operational burden for clinical...
Specialdocs Consultants is a growing Northshore healthcare consulting firm in the business of transforming physicians’ practices across the country to concierge medicine models and bringing medicine back to the way it used to be practiced.
Real Chemistry is a global health innovation company with offices across the United States and Europe. We believe that the way to real, transformative change is through the uncommon combination of disciplines, technologies, and our greatest asset – our people. We are currently looking to add to our alchemic mix of more than 1,800 talented professionals.
United Woundcare Institute delivers expert wound healing wherever patients need it, utilizing a science-led, patient-centered model to ensure continuity of care and faster recovery.
OnePoint Patient Care is a company that provides patient care services and focuses on new customer acquisition.
NYC Health + Hospitals is the nation’s largest public health care delivery system. We are an integrated network of hospitals, trauma centers, neighborhood health centers, nursing homes, and post-acute care centers. We are a home care agency and a health plan, MetroPlus. The health system provides essential services to more than 1.4 million New Yorkers every year in more than...
At SkinIO, our mission is to make skin cancer screening and skin health monitoring accessible, whether at the doctor's office or in the comfort of home. The challenge of skin cancer is not that there isn’t a cure; it is that we are not detecting skin cancer early enough. We aim to make skin cancer screening and skin health monitoring accessible,...
ADVENT is an ear, nose and throat (ENT) medical practice focused on office-based care for nasal blockage, sinus infections, snoring and sleep apnea. Its team-based model emphasizes a purposeful patient experience and minimally invasive solutions, including in-office CT scans, at-home sleep studies and procedures with little to no downtime. The company’s mission is to deliver healthy breathing and improve patients’...
Mercyhealth is a non-profit regional health care system based in Rockford, Illinois, serving communities throughout southern Wisconsin and northern Illinois. The organization operates a vertically integrated system encompassing hospital-based services, clinic-based services, post-acute care, retail services, and its own wholly owned insurance company, MercyCare Health Plans.
Complex NTWRK champions the people, brands and new trends you need to know now, will obsess over next, and we build consumer universes around them. We're what a modern entertainment company looks like and what others have followed since 2002. From pop culture and style (Complex), music discovery (Pigeons and Planes), sneaker news (Sole Collector) to our festival of cultural...
NurseDash is aprovider of healthcare staffing application intended to streamline the hiring process connecting directly to qualified nurses.




.png)




























